These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 26981712

  • 1. L-Tetrahydropalmatine alleviates mechanical hyperalgesia in models of chronic inflammatory and neuropathic pain in mice.
    Zhou HH, Wu DL, Gao LY, Fang Y, Ge WH.
    Neuroreport; 2016 May 04; 27(7):476-80. PubMed ID: 26981712
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dopamine D1 and D2 receptors mediate analgesic and hypnotic effects of l-tetrahydropalmatine in a mouse neuropathic pain model.
    Liu YY, Wang TX, Zhou JC, Qu WM, Huang ZL.
    Psychopharmacology (Berl); 2019 Nov 04; 236(11):3169-3182. PubMed ID: 31172225
    [Abstract] [Full Text] [Related]

  • 5. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
    Nirogi R, Jabaris SL, Jayarajan P, Abraham R, Shanmuganathan D, Rasheed MA, Royapalley PK, Goura V.
    Eur J Pharmacol; 2011 Oct 01; 668(1-2):155-62. PubMed ID: 21756895
    [Abstract] [Full Text] [Related]

  • 6. Antihyperalgesic effects of myrsinoic acid B in pain-like behavior induced by inflammatory and neuropathic pain models in mice.
    Antonialli Cde S, da Silva GF, Rocha LW, Monteiro ER, de Souza MM, Malheiros A, Yunes RA, Quintão NL.
    Anesth Analg; 2012 Aug 01; 115(2):461-9. PubMed ID: 22523418
    [Abstract] [Full Text] [Related]

  • 7. Antinociceptive Profile of Levo-tetrahydropalmatine in Acute and Chronic Pain Mice Models: Role of spinal sigma-1 receptor.
    Kang DW, Moon JY, Choi JG, Kang SY, Ryu Y, Park JB, Lee JH, Kim HW.
    Sci Rep; 2016 Dec 02; 6():37850. PubMed ID: 27910870
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat.
    Honore P, Donnelly-Roberts D, Namovic MT, Hsieh G, Zhu CZ, Mikusa JP, Hernandez G, Zhong C, Gauvin DM, Chandran P, Harris R, Medrano AP, Carroll W, Marsh K, Sullivan JP, Faltynek CR, Jarvis MF.
    J Pharmacol Exp Ther; 2006 Dec 02; 319(3):1376-85. PubMed ID: 16982702
    [Abstract] [Full Text] [Related]

  • 11. Intrathecally administered pizotifen alleviates neuropathic and inflammatory pain in mice by enhancing GABAergic inhibition.
    Li J, Zhang X, Xu C, Liu YX, Ge C, Zhao Z, Zhu YB, Bao HG.
    Neurosci Lett; 2022 Apr 01; 775():136545. PubMed ID: 35202750
    [Abstract] [Full Text] [Related]

  • 12. NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors.
    Berger ND, Gadotti VM, Petrov RR, Chapman K, Diaz P, Zamponi GW.
    Mol Pain; 2014 Dec 06; 10():77. PubMed ID: 25481027
    [Abstract] [Full Text] [Related]

  • 13. S1RA, a selective sigma-1 receptor antagonist, inhibits inflammatory pain in the carrageenan and complete Freund's adjuvant models in mice.
    Gris G, Merlos M, Vela JM, Zamanillo D, Portillo-Salido E.
    Behav Pharmacol; 2014 Jun 06; 25(3):226-35. PubMed ID: 24776490
    [Abstract] [Full Text] [Related]

  • 14. Increased tumor necrosis factor-alpha and prostaglandin E2 concentrations in the cerebrospinal fluid of rats with inflammatory hyperalgesia: the effects of analgesic drugs.
    Bianchi M, Martucci C, Ferrario P, Franchi S, Sacerdote P.
    Anesth Analg; 2007 Apr 06; 104(4):949-54. PubMed ID: 17377112
    [Abstract] [Full Text] [Related]

  • 15. Involvement of the TTX-resistant sodium channel Nav 1.8 in inflammatory and neuropathic, but not post-operative, pain states.
    Joshi SK, Mikusa JP, Hernandez G, Baker S, Shieh CC, Neelands T, Zhang XF, Niforatos W, Kage K, Han P, Krafte D, Faltynek C, Sullivan JP, Jarvis MF, Honore P.
    Pain; 2006 Jul 06; 123(1-2):75-82. PubMed ID: 16545521
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain.
    Schiene K, De Vry J, Tzschentke TM.
    J Pharmacol Exp Ther; 2011 Nov 06; 339(2):537-44. PubMed ID: 21816956
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats.
    Honore P, Wismer CT, Mikusa J, Zhu CZ, Zhong C, Gauvin DM, Gomtsyan A, El Kouhen R, Lee CH, Marsh K, Sullivan JP, Faltynek CR, Jarvis MF.
    J Pharmacol Exp Ther; 2005 Jul 06; 314(1):410-21. PubMed ID: 15837818
    [Abstract] [Full Text] [Related]

  • 20. The antihyperalgesic effects of intrathecal bupropion, a dopamine and noradrenaline reuptake inhibitor, in a rat model of neuropathic pain.
    Hoshino H, Obata H, Nakajima K, Mieda R, Saito S.
    Anesth Analg; 2015 Feb 06; 120(2):460-6. PubMed ID: 25427287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.